5,6-dihydroxytryptamine has been researched along with mecamylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beleslin, DB; Nedelkovski, V | 1 |
| Beleslin, DB; Strbac, M | 1 |
| Beleslin, DB; Jovanovic-Micic, D; Tomic-Beleslin, N | 1 |
3 other study(ies) available for 5,6-dihydroxytryptamine and mecamylamine
| Article | Year |
|---|---|
Emesis induced by 4-(m-chlorophenylcarbamoyloxy)-2-butynyltrimethylammonium chloride (McN-A-343): evidence for a predominant central muscarinic M1 mediation.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; 5,6-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Antazoline; Bretylium Compounds; Cats; Chlorpromazine; Choline; Emetics; Female; Hemicholinium 3; Hexamethonium Compounds; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Neuromuscular Blocking Agents; Propranolol; Quaternary Ammonium Compounds; Receptors, Muscarinic; Reserpine; Yohimbine | 1988 |
Noradrenaline-induced emesis. Alpha-2 adrenoceptor mediation in the area postrema.
Topics: 5,6-Dihydroxytryptamine; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; alpha-Methyltyrosine; Animals; Atropine; Bretylium Compounds; Cats; Cerebral Ventricles; Copper; Copper Sulfate; Ethylenediamines; Female; Hemicholinium 3; Injections, Intraventricular; Male; Mecamylamine; Methyltyrosines; Methysergide; Norepinephrine; Receptors, Adrenergic, alpha; Reserpine; Vomiting | 1987 |
Nature of salivation produced by thyrotropin-releasing hormone (TRH).
Topics: 5,6-Dihydroxytryptamine; Animals; Atropine; Cats; Female; Hemicholinium 3; Hydroxydopamines; Male; Mecamylamine; Oxidopamine; Reserpine; Salivation; Thyrotropin-Releasing Hormone | 1987 |